Quest Diagnostics Incorporated DGX
236.32
(0.27)
(0.11%)
as of 25 Sep
- Market cap
- $26.2B
- P/E
- 24.8×
Follow DGX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Quest Diagnostics Incorporated (DGX) Free cash flow margin
Quest Diagnostics Incorporated's free cash flow margin over the twelve months to 30 June 2026 was 11.7%, down 0.7 percentage points from fiscal 2025 (12.3%). Over the past ten years it has ranged from 7.45% (fiscal 2015) to 17.0% (fiscal 2021); the current reading is higher than 64% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 12.3% | 3.11 |
| FY2024 | 9.21% | (0.13) |
| FY2023 | 9.34% | (3.96) |
| FY2022 | 13.3% | (3.66) |
| FY2021 | 17.0% | 0.14 |
| FY2020 | 16.8% | 5.91 |
| FY2019 | 10.9% | 0.06 |
| FY2018 | 10.9% | (1.62) |
| FY2017 | 12.5% | 1.06 |
| FY2016 | 11.4% | 3.96 |
Against its own ten years
Low 7.45%
High 17.0%
Ten-year median
11.4%
Current reading's percentile
64
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 27.2% |
| MEDP Medpace Holdings, Inc. compare | 25.4% |
| MTD Mettler-Toledo International, Inc. compare | 20.9% |
| ILMN Illumina, Inc. compare | 20.7% |
| RVTY Revvity Inc. compare | 19.6% |
| DGX Quest Diagnostics Incorporated | 11.7% |
| LH Labcorp Holdings Inc. compare | 8.16% |
| WAT Waters Corporation compare | 7.89% |
| GH Guardant Health, Inc. compare | −20.4% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on DGX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement